Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

ClinicalTrials.gov ID: NCT03187301

Public ClinicalTrials.gov record NCT03187301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Study identification

NCT ID
NCT03187301
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
48 participants

Conditions and interventions

Interventions

  • APL-130277 Drug
  • Placebo Drug
  • Moxifloxacin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2, 2017
Primary completion
Dec 20, 2017
Completion
Dec 20, 2017
Last update posted
Aug 9, 2020

2017

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Movement Disorders Center of Arizona Scottsdale Arizona 85258
Clinical Trials, Inc. Little Rock Arkansas 72205
The Parkinson's and Movement Disorder Institute Fountain Valley California 92708
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486
MD Clinical Hallandale Florida 33009
Bioclinica Reserach Orlando Florida 32806
Atlanta Center for Medical Research Atlanta Georgia 30331
The NeuroMedical Center, PC Baton Rouge Louisiana 70810
QUEST Research Institute Farmington Hills Michigan 48334
Central Texas Neurology Consultants Round Rock Texas 78681

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03187301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03187301 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →